Author holds a large long stock position in Rocket Lab across multiple accounts (bought from $9 to $50), with unrealized gains of $1.1M. Strong conviction in the space company with no intention to sell, signaling belief in further upside.
RKLB is well-positioned for long-term growth in the space sector. After trimming options pre-IPO, the author plans to reinvest in space stocks including RKLB once the SpaceX IPO settles.
Author bought Rocket Lab ahead of anticipated SpaceX IPO announcement and captured $1.3M gain in 2 weeks by riding the run-up momentum. Trade was based on SpaceX IPO catalyst.
Author has held RKLB since $4.35 and continues to add to position, expressing a long-term bullish stance on Rocket Lab despite not having gone all-in due to capital constraints.
Rocket Lab is a long-term fundamental holding with superior management (Peter Beck, Adam Spice) and a dominant position in small payload launches. Neutron's expansion into mid-size payloads combined with satellite manufacturing assets positions RKLB across the entire space economy value chain, and at current valuations appears underpriced relative to SpaceX's ~$1.75T valuation.
Author made $7k from RKLB shares, confirming a successful bullish position that motivated further options trading experimentation.
RKLB has performed well enough that the author regrets not holding a larger position, implying confidence in further upside or satisfaction with the returns achieved.
RKLB delivered significant gains, turning a $456 position into $12,500. Author is bullish on the stock's upside performance.
Rocket Lab stock has risen ~800% in recent years despite fundamentals not justifying the valuation. The author views this as speculative excess driven by AI/tech hype rather than sustainable business growth.
Author successfully executed a covered call spread strategy (short puts financed long calls) on RKLB around $50 in December 2025, generating $115,500 in gains. The realized profit demonstrates confidence in the position and validates the bullish directional bet.
Author is heavily long Rocket Lab and continuing to accumulate despite substantial unrealized gains, signaling conviction in further upside with no intention to exit.
Author has added puts on RKLB as part of a broader bearish positioning strategy (alongside SOXX shorts/puts). The post implies expectation of price decline this week.
Author has held 10k shares of RKLB for 4 years through significant gains, sold some shares to fund a house purchase, and is keeping the remainder invested. This reflects conviction in RKLB as a good long-term company with continued upside potential.
Author is holding a large multi-hundred-thousand-dollar position in RKLB with conviction for long-term growth, suggesting confidence in the company's prospects.
Rocket Lab (RKLB) is a multi-decade growth opportunity with strong momentum. The author has been holding the position and is celebrating gains, positioning it as a major trade for the coming decades.
SpaceX IPO will drive valuations higher for space industry peers. RKLB has major catalysts this year and will benefit from IPO momentum until near that event.
Author exited 68 contracts profitably but acknowledges upside potential for the stock to reach $130 before July, suggesting underlying bullish bias despite taking profits early.
Author made a profitable options bet on RKLB calls, up 560% in a single day, demonstrating conviction in the position and analytical edge rather than luck.
Rocket Lab beat revenue expectations and signed its largest launch deal ever with multiple Neutron and Electron missions planned. Strong Q1 performance and forward guidance suggest the company is executing on growth despite elevated Q2 EBITDA guidance.
Rocket Lab positioned as one of two dominant western spaceflight providers alongside SpaceX, with Neutron launch vehicle capturing market share from Blue Origin and ULA due to cost and execution advantages. Amazon's Kuiper satellite constellation likely to contract with RKLB before achieving scale with competitor New Glenn.